TLX 1.65% $18.48 telix pharmaceuticals limited

Expensive IPO....definitely not worth the money, look at the...

  1. 25 Posts.
    lightbulb Created with Sketch. 2
    Expensive IPO....definitely not worth the money, look at the salaries and directors fees... ridiculous.
    Would probably get better value out of buying Oncosil...
    I wonder if Chris is still pursuing self promotion through his research company now that he is in "real" business.
    Hopefully his contribution will be more meaningful to Telix compared to Factor therapeutics.
    At least Andreas Kluge is a respected professional.

    TLX a concoction of licenses yet to be paid.....Wishful thinking in a full moon, tranquil August night.

    Best of luck to the investors
 
watchlist Created with Sketch. Add TLX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.